| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/01/2023 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (Right to Buy) | 50k | $1.41 | $70.5k | | 07/01/2023 |
| 05/03/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 3.5k | $0.00 | $0 | | 05/03/2023 |
| 05/03/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 5.9k | $33.61 | $198.8k | | 05/03/2023 |
| 09/29/2022 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 5k | $0.00 | $0 | | 09/29/2022 |
| 08/18/2022 | TherapeuticsMD, Inc. | TXMD | Exercise | Restricted Stock Units | 2k | $0.00 | $0 | | 08/18/2022 |
| 07/01/2022 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (right to buy) | 50k | $1.57 | $78.5k | | 07/01/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 6.1k | $0.00 | $0 | | 05/04/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 11.3k | $18.12 | $205.5k | | 05/04/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 10.8k | $18.12 | $194.9k | | 05/04/2022 |
| 12/13/2021 | Revance Therapeutics, Inc. | RVNC | Purchase | Common Stock | 6.4k | $15.74 | $100.7k | | 12/13/2021 |
| 08/10/2021 | TherapeuticsMD, Inc. | TXMD | Exercise | Restricted Stock Units | 96.9k | $0.00 | $0 | | 08/10/2021 |
| 07/01/2021 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 99.2k | $0.00 | $0 | | 07/01/2021 |
| 05/05/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 7.6k | $27.91 | $210.7k | | 05/05/2021 |
| 05/05/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 4k | $0.00 | $0 | | 05/05/2021 |
| 11/12/2020 | Mallinckrodt plc | MNK | Sale | Ordinary Shares | 51.8k | $0.13 | $6.7k | | 11/12/2020 |
| 07/01/2020 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (Right to Buy) | 40k | $0.83 | $33.1k | | 07/01/2020 |
| 06/18/2020 | TherapeuticsMD, Inc. | TXMD | Grant | Restricted Stock Units | 96.9k | $0.00 | $0 | | 06/18/2020 |
| 05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 12k | $19.40 | $232.8k | | 05/14/2020 |
| 05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 6k | $0.00 | $0 | | 05/14/2020 |
| 05/13/2020 | Mallinckrodt plc | MNK | Payment of Exercise | Ordinary Shares | 12k | $2.96 | $35.6k | | 05/13/2020 |
| 08/23/2019 | TherapeuticsMD, Inc. | TXMD | Purchase | Common Stock | 10k | $2.77 | $27.7k | | 08/23/2019 |
| 08/15/2019 | TherapeuticsMD, Inc. | TXMD | Purchase | Common Stock | 10k | $2.99 | $29.9k | | 08/14/2019 |
| 08/14/2019 | TherapeuticsMD, Inc. | TXMD | Purchase | Common Stock | 25k | $2.76 | $69k | | 08/14/2019 |
| 07/01/2019 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (Right to Buy) | 40k | $1.03 | $41.2k | | 07/01/2019 |
| 06/20/2019 | TherapeuticsMD, Inc. | TXMD | Grant | Non-Qualified Stock Option (right to buy) | 75k | $2.64 | $198k | | 06/20/2019 |
| 05/15/2019 | Mallinckrodt plc | MNK | Grant | Ordinary Shares | 26.8k | $0.00 | $0 | | 05/15/2019 |
| 05/15/2019 | Mallinckrodt plc | MNK | Payment of Exercise | Ordinary Shares | 11.8k | $15.21 | $178.9k | | 05/15/2019 |
| 05/09/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 9k | $12.82 | $115.4k | | 05/09/2019 |
| 05/09/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 4.5k | $0.00 | $0 | | 05/09/2019 |
| 07/02/2018 | TherapeuticsMD, Inc. | TXMD | Grant | Non-Qualified Stock Option (right to buy) | 50k | $6.35 | $317.5k | | 07/02/2018 |
| 07/01/2018 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 40k | $2.06 | $82.4k | | 07/01/2018 |
| 05/16/2018 | Mallinckrodt plc | MNK | Grant | Ordinary Shares | 26.1k | $0.00 | $0 | | 05/16/2018 |
| 05/10/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 3k | $0.00 | $0 | | 05/10/2018 |
| 05/10/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 6k | $29.15 | $174.9k | | 05/10/2018 |
| 03/01/2018 | Mallinckrodt plc | MNK | Payment of Exercise | Ordinary Shares | 2.6k | $15.68 | $40.4k | | 03/01/2018 |
|